BOD
Names
Preferred IUPAC name
2-(2,5-Dimethoxy-4-methylphenyl)-2-methoxyethan-1-amine
Other names
4-Methyl-2,5,β-trimethoxyphenethylamine
2-(4-Methyl-2,5,β-trimethoxyphenyl)ethanamine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C12H19NO3/c1-8-5-11(15-3)9(6-10(8)14-2)12(7-13)16-4/h5-6,12H,7,13H2,1-4H3 checkY
    Key: VTEIFHQUZWABDE-UHFFFAOYSA-N checkY
  • InChI=1/C12H19NO3/c1-8-5-11(15-3)9(6-10(8)14-2)12(7-13)16-4/h5-6,12H,7,13H2,1-4H3
    Key: VTEIFHQUZWABDE-UHFFFAOYAC
  • COc1cc(C)c(cc1C(CN)OC)OC
Properties
C12H19NO3
Molar mass 225.288 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

BOD (4-methyl-2,5,β-trimethoxyphenethylamine) is a lesser-known psychedelic drug. It is the beta-methoxy analog of 2C-D and was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 15–25 mg with a duration of 8–16 hours.[1] Its reported effects include mild open-eye and moderate closed-eye alterations in visual perception, enhancement of conversation and sense of humor, and unpleasant physical effects such as nausea and lethargy.[2] Very little data exists about the pharmacological properties, metabolism, and toxicity of BOD.

Legality

United States

BOD is unscheduled in the United States, but purchase, sale, or possession for human consumption could be prosecuted under the Federal Analogue Act.[3]

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[4]

See also

References

  1. ^ BOD Entry in PiHKAL
  2. ^ Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
  3. ^ "21 U.S. Code § 841 - Prohibited acts A", LII / Legal Information Institute, retrieved 2016-08-02
  4. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.
source: http://en.wikipedia.org/wiki/BOD_(psychedelic)